title: Update on pediatric psoriasis, Part 2: Therapeutic management.
abstract: Pediatric psoriasis is an autoimmune diathesis with a complex immunologic basis. It is associated with extensive psychological morbidity and should be treated rapidly and effectively to limit psychologic effects on children. The most common trigger in childhood is upper respiratory tract infection. Once disease has occurred, treatment is based on severity and presence of joint involvement. Topical therapies include corticosteroids and calcipotriene. UV light, systemic retinoids, and cyclosporine remit cutaneous psoriatic lesions. Methotrexate sodium and etanercept benefit both skin and joint manifestations of psoriasis. Concern for psychological symptoms and psychological growth is needed in treating pediatric patients with psoriasis vulgaris.
authors.affiliation: Pediatric and Adolescent Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Ste 11D, New York, NY 10025, USA. nsilverb@chpnet.org
authors.forename: Nanette B
authors.initials: NB
authors.lastname: Silverberg
mesh_terms: D002648:Child; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019587:Dietary Supplements; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D011565:Psoriasis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D012720:Severity of Illness Index
chemical_list: D003879:Dermatologic Agents; D007155:Immunologic Factors